A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis-Reference-Cited by-全球学者库

A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis

Published:2021-02-28 Issue:3 Volume:73 Page:1105-1116
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Gindin Yevgeniy¹,Chung Chuhan¹,Jiang Zhaoshi¹,Zhou Jing Zhu¹,Xu Jun¹,Billin Andrew N.¹,Myers Robert P.¹,Goodman Zachary²,Landi Abdolamir³,Houghton Michael³,Green Richard M.⁴,Levy Cynthia⁵,Kowdley Kris V.⁶,Bowlus Christopher L.⁷,Muir Andrew J.⁸^ORCID,Trauner Michael⁹

Affiliation:

1. Gilead Sciences, Inc. Foster City CA

2. Inova Fairfax Hospital Falls Church VA

3. Department of Medical Microbiology and Immunology Li Ka Shing Institute of VirologyUniversity of Alberta Edmonton AB Canada

4. Division of Gastroenterology and Hepatology Department of Medicine Feinberg School of Medicine at Northwestern University Chicago IL

5. University of Miami Miami FL

6. Liver Institute Northwest Seattle WA

7. Division of Gastroenterology and Hepatology University of California at Davis Sacramento CA

8. Duke University School of Medicine Durham NC

9. Division of Gastroenterology and Hepatology Department of Medicine III Medical University of Vienna Vienna Austria

Funder

Gilead Sciences